- Home
- NUTX vs HQL Comparison
NUTX vs HQL Comparison
Compare NUTX & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUTX
- HQL
- Stock Information
- Founded
- NUTX 2011
- HQL 1992
- Country
- NUTX United States
- HQL United States
- Employees
- NUTX N/A
- HQL N/A
- Industry
- NUTX Retail: Computer Software & Peripheral Equipment
- HQL Investment Managers
- Sector
- NUTX Technology
- HQL Finance
- Exchange
- NUTX Nasdaq
- HQL Nasdaq
- Market Cap
- NUTX 358.7M
- HQL 372.7M
- IPO Year
- NUTX N/A
- HQL N/A
- Fundamental
- Price
- NUTX $57.60
- HQL $13.85
- Analyst Decision
- NUTX Strong Buy
- HQL
- Analyst Count
- NUTX 2
- HQL 0
- Target Price
- NUTX $55.00
- HQL N/A
- AVG Volume (30 Days)
- NUTX 48.5K
- HQL 120.9K
- Earning Date
- NUTX 03-27-2025
- HQL 01-01-0001
- Dividend Yield
- NUTX N/A
- HQL 11.56%
- EPS Growth
- NUTX N/A
- HQL N/A
- EPS
- NUTX N/A
- HQL 0.79
- Revenue
- NUTX $292,000,390.00
- HQL N/A
- Revenue This Year
- NUTX $25.00
- HQL N/A
- Revenue Next Year
- NUTX $14.40
- HQL N/A
- P/E Ratio
- NUTX N/A
- HQL $17.08
- Revenue Growth
- NUTX 26.02
- HQL N/A
- 52 Week Low
- NUTX $4.16
- HQL $11.34
- 52 Week High
- NUTX $69.45
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- NUTX 58.19
- HQL 46.39
- Support Level
- NUTX $60.67
- HQL $13.66
- Resistance Level
- NUTX $67.67
- HQL $14.41
- Average True Range (ATR)
- NUTX 5.33
- HQL 0.20
- MACD
- NUTX -0.02
- HQL -0.01
- Stochastic Oscillator
- NUTX 53.27
- HQL 24.34
About NUTX Nutex Health Inc.
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.